Objective: Visual hallucinations are common in Parkinson’s disease (PD) and associated with worse outcomes. Large-scale network imbalance is seen in PD-associated hallucinations, but mechanisms remain unclear. As the thalamus is critical in controlling cortical networks, structural thalamic changes could underlie network dysfunction in PD hallucinations. Methods: We used whole-brain fixel-based analysis and cortical thickness measures to examine longitudinal white and grey matter changes in 76 patients with PD (15 hallucinators, 61 non-hallucinators) and 26 controls at baseline, and after 18 months. We compared white matter and cortical thickness, adjusting for age, gender, time-between-scans and intracranial volume. To assess ...
Damage to fiber tracts connecting the nucleus basalis of Meynert (NBM) to the cerebral cortex may un...
BACKGROUND: Visual hallucinations (VH) are one of the most striking nonmotor symptoms in Parkinson's...
Parkinson's disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminergic...
Visual hallucinations are common in Parkinson’s disease (PD) and linked to worse outcomes: increased...
Inefficient integration between bottom-up visual input and higher order visual processing regions is...
Hallucinations are common in Parkinson’s disease (PD). Based on functional brain MRI data, hallucina...
Parkinson's psychosis (PDP) describes a spectrum of symptoms that may arise in Parkinson's disease (...
Visual hallucinations (VH) are common in Parkinson's disease (PD) and lead to a poor quality of life...
Abstract Background Recent pathological studies have suggested that thalamic degeneration may repres...
Visual hallucinations in Parkinson’s disease can be viewed from a systems-level perspective, whereby...
BackgroundMinor hallucination (MH) is the most common psychotic symptom in Parkinson’s disease (PD);...
BackgroundMinor hallucination (MH) is the most common psychotic symptom in Parkinson’s disease (PD);...
Background Visual hallucinations (VH) are an important non-motor complication of Parkinson’s disea...
Hallucinations are a core feature of psychosis and common in Parkinson’s. Their transient, unexpecte...
Parkinson\u27s disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminer...
Damage to fiber tracts connecting the nucleus basalis of Meynert (NBM) to the cerebral cortex may un...
BACKGROUND: Visual hallucinations (VH) are one of the most striking nonmotor symptoms in Parkinson's...
Parkinson's disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminergic...
Visual hallucinations are common in Parkinson’s disease (PD) and linked to worse outcomes: increased...
Inefficient integration between bottom-up visual input and higher order visual processing regions is...
Hallucinations are common in Parkinson’s disease (PD). Based on functional brain MRI data, hallucina...
Parkinson's psychosis (PDP) describes a spectrum of symptoms that may arise in Parkinson's disease (...
Visual hallucinations (VH) are common in Parkinson's disease (PD) and lead to a poor quality of life...
Abstract Background Recent pathological studies have suggested that thalamic degeneration may repres...
Visual hallucinations in Parkinson’s disease can be viewed from a systems-level perspective, whereby...
BackgroundMinor hallucination (MH) is the most common psychotic symptom in Parkinson’s disease (PD);...
BackgroundMinor hallucination (MH) is the most common psychotic symptom in Parkinson’s disease (PD);...
Background Visual hallucinations (VH) are an important non-motor complication of Parkinson’s disea...
Hallucinations are a core feature of psychosis and common in Parkinson’s. Their transient, unexpecte...
Parkinson\u27s disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminer...
Damage to fiber tracts connecting the nucleus basalis of Meynert (NBM) to the cerebral cortex may un...
BACKGROUND: Visual hallucinations (VH) are one of the most striking nonmotor symptoms in Parkinson's...
Parkinson's disease (PD) affects 2-3% of the population over the age of 65 with loss of dopaminergic...